Prevalence of pathogenicity island IICFT073 genes among extraintestinal clinical isolates of Escherichia coli by Parham, Nick J. et al.
JOURNAL OF CLINICAL MICROBIOLOGY, May 2005, p. 2425–2434 Vol. 43, No. 5
0095-1137/05/$08.000 doi:10.1128/JCM.43.5.2425–2434.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Prevalence of Pathogenicity Island IICFT073 Genes among
Extraintestinal Clinical Isolates of Escherichia coli
Nick J. Parham,1 Samantha J. Pollard,1 Roy R. Chaudhuri,1 Scott A. Beatson,1
Mickae¨l Desvaux,1 Michael A. Russell,1 Joaquim Ruiz,2 Amanda Fivian,1
Jordi Vila,2 and Ian R. Henderson1*
Bacterial Pathogenesis and Genomics Unit, Division of Immunity and Infection,
University of Birmingham, Birmingham B15 2TT, United Kingdom,1 and
Servei de Microbiologia,Institut Clinic Infecciones I Immunologia,
Hospital Clinic-IDIBAPS, Barcelona, Spain2
Received 2 November 2004/Returned for modification 7 January 2005/Accepted 24 January 2005
Uropathogenic Escherichia coli is the most common cause of urinary tract infection (UTI). Cystitis in women
is by far the most common UTI; pyelonephritis in both sexes and prostatitis in men are more severe but are
less frequent complaints. The ability of E. coli to cause UTI is associated with specific virulence determinants,
some of which are encoded on pathogenicity islands (PAI). One such PAI (PAI IICFT073), of the prototypical
uropathogenic E. coli strain CFT073, contains 116 open reading frames, including iron-regulated genes,
carbohydrate biosynthetic genes, the serine protease autotransporter picU, a two-partner secretion system, a
type I secretion system, mobility genes, and a large number of hypothetical genes. To determine the association
of PAI IICFT073 with UTI, PCR was used to examine the prevalence of the five virulence-associated loci among
the ECOR collection and a collection of E. coli isolated from patients with cystitis, pyelonephritis, prostatitis,
or septicemia. All PAI IICFT073 loci were found to be more prevalent among the B2 phylogenetic group than any
other group within the ECOR collection and among invasive prostatitis strains than were cystitis or pyelone-
phritis strains. These data support the theory that clinical isolates causing prostatitis are more virulent than
those producing cystitis or pyelonephritis in women.
Urinary tract infections (UTIs) continue to be among the
most common extraintestinal diseases. In the United States,
UTIs account for 8.7 million annual physician and 2.3 million
hospital visits (49). Cystitis in women is by far the most com-
mon UTI; pyelonephritis in both sexes and prostatitis in men
are more severe but less frequent complaints. Several bacterial
species may cause UTIs, but Escherichia coli is by far the most
common cause (14), accounting for 50% of all nosocomial
UTIs and 90% of infections among ambulatory patients.
It is believed that uropathogenic E. coli (UPEC) are adapted
to colonizing the urinary tract. The liberation of specific viru-
lence factors may aid attachment to host mucosal tissue, allow
evasion of immune defenses, and promote invasion of the
normally sterile urinary tract and tissues (14, 15). Among these
factors, adhesins, capsule, aerobactin, toxins, and proteases
have been described (1, 15, 36, 46). Analysis of the prevalence
of virulence factors among commensal E. coli and those caus-
ing different UTIs has indicated a greater virulence potential
of the disease-causing strains (18, 33, 46). Moreover, virulence
determinants appear to be more prevalent among strains caus-
ing invasive disease (46). Interestingly, half of all UPEC iso-
lates possess none, or only one, of the virulence factors char-
acterized thus far. As such, it is reasonable to assume other,
as-yet-uncharacterized, bacterial factors may be important in
the pathogenesis of UTI (33).
The genome sequence of the UPEC strain CFT073 has
been determined, and this has allowed the identification of
potential virulence genes (54). Several of the genes associ-
ated with the acquisition and development of UTIs are
encoded on pathogenicity islands (PAIs), e.g., hemolysin
and P fimbriae (3). By definition, PAIs contain genes that
are associated with virulence and are absent from avirulent
or less virulent strains of the same species. Multiple PAIs
varying in size and gene complement have been described in
UPEC isolates (2, 13, 34). Recently, we described the exis-
tence within uropathogenic E. coli strains of the serine pro-
tease autotransporter PicU (40). In silico analysis of the
genomic context of the gene encoding PicU revealed that,
like other virulence factors, it was located on a PAI. The
100-kb PAI contains 116 open reading frames (ORFs)
which, in addition to PicU, encode a type I protein secretion
system, a member of the two-partner protein secretion sys-
tem (TPSS), iron-sequestering proteins, proteins involved in
carbohydrate metabolism, insertion elements, and ORFs of
unknown function. The PAI encoding PicU demonstrates
homology with PAI IICFT073, a 71.6-kb PAI previously char-
acterized in E. coli CFT073 (43). In silico investigations of
the previously described PAI IICFT073 revealed that it was
incorrectly assembled from three distinct regions of the E.
coli CFT073 complete genome sequence. Here we describe
the correct genetic organization of PAI IICFT073 and inves-
tigate the prevalence of these genes among populations of
E. coli including pathogenic E. coli causing cystitis and py-
elonephritis in women, prostatitis in men, and septicemia in
both sexes.
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MATERIALS AND METHODS
Bioinformatic analysis of the E. coli CFT073 genome. To characterize the
genomic context of the gene encoding the PicU autotransporter, the E. coli
CFT073 genome sequence was compared to other E. coli and Shigella strains by
using coliBASE (http://colibase.bham.ac.uk), an online database for E. coli com-
parative genomics (6). This contains all of the complete E. coli, Shigella, and
Salmonella genome sequences, together with preliminary data from a number of
sequencing projects currently in progress at The Wellcome Trust Sanger Insti-
tute. The database contains precalculated genome alignments performed by
using MUMmer and PROmer (6, 10) and provides user-friendly tools to display
pairwise comparisons between equivalent regions of different strains to highlight
chromosomal insertions, deletions, and rearrangements.
Bacterial strains and growth conditions. Ninety-four E. coli strains causing
cystitis or pyelonephritis in women or prostatitis in men were obtained from J.
Ruiz (Barcelona, Spain). These strains were previously characterized for preva-
lence of nine uropathogenic virulence factors (46). The ECOR collection, a
phylogenetically characterized collection of E. coli strains representing the four
major phylogenetic groups (A, B1, B2, and D) (38), was obtained from M. J.
Pallen (University of Birmingham, Birmingham, United Kingdom). A collection
of 43 consecutive E. coli blood culture isolates were obtained from the clinical
laboratories at the Queen Elizabeth Hospital in Birmingham in 2003. All strains
were grown overnight at 37°C on LB agar plates to check purity. Overnight LB
broth cultures were then used for DNA preparations by using the DNeasy tissue
kit (Qiagen, Crawley, United Kingdom), according to the manufacturer’s instruc-
tions. The prototypical UPEC strain CFT073 was kindly provided by H. L. T.
Mobley.
Phylogenetic grouping of the blood culture isolates was performed by using the
method described by Clermont et al. (7). Briefly, DNA from all strains was
amplified with primers for chuA, positive samples were subsequently amplified
with primers corresponding to yjaA, whereas negative samples were amplified
with primers corresponding to tspE4C2 as follows: samples positive for yjaA
represent the B2 cluster, samples negative for yjaA represent the D group,
samples positive for tspE4C2 represent the B1 cluster, and samples negative for
tspE4C2 represent the A group. Primers are listed in Table 1.
PCR detection of potential virulence genes. The gene-specific PCR primers
used in the present study were designed against the PAI nucleotide sequence of
UPEC strain CFT073 (54). Primers are listed in Table 1. Genomic DNA prep-
arations were tested for these genes in 50-l PCR mixtures containing 15 pmol
of each of the forward and reverse primers, 10 nmol of each deoxynucleoside
triphosphate, 1 U of Taq DNA polymerase (Invitrogen, Paisley, United King-
dom), and 2 mM MgCl2 in 1 PCR buffer (Invitrogen). The PCR conditions
were as follows: initial incubation at 94°C for 2 min, followed by 30 cycles of
denaturation at 94°C for 15 s, annealing at 55°C for 30s, and extension at 72°C
for 45 s. A final extension step of 72°C for 10 min was also included. Products
were analyzed by electrophoresis through 0.8% (wt/vol) gels with ethidium bro-
mide as visualization agent. The sizes of amplicons were determined by compar-
ison to the 1-kb plus DNA ladder (Invitrogen). E. coli K-12 (MG1655) and
UPEC E. coli CFT073 were used as negative and positive controls, respectively,
in all assays. Negative reactions were retested with annealing at 45 and 50°C to
allow for small variations in primer-site sequence between strains. The preva-
lence data was analyzed online (http://www.matforsk.no/ola/fisher.htm) by using
a two-tailed Fisher exact test to test for statistical significance.
RESULTS
Correct structure and gene content of PAI IICFT073. We
previously identified a mucinase termed PicU in the UPEC
strain CFT073 (40). PicU is a serine protease autotransporter
of the Enterobacteriaceae (SPATE) demonstrating a high level
of homology (95% identity) with the previously described PAI-
encoded Pic mucinase of enteroaggregative E. coli and S. flex-
neri 2a (21). Analysis of the E. coli CFT073 genome sequence
indicated that picU was present on a 100-kb PAI inserted
between the E. coli K-12 genes dnaQ and yafV (see Fig. 1A).
This region of the K-12 genome includes two genes, yafT and
yafU, which are absent from E. coli CFT073, and the aspV
tRNA gene, which is present in both genomes. Comparison of
E. coli O157:H7, S. flexneri 2a, and EAEC 042 with E. coli K-12
demonstrates that each strain possesses a PAI inserted be-
tween dnaQ and yafV. These inserts are dissimilar to each
other (data not shown) differing in size (36.0, 57.6, and 31.3 kb,
respectively) and gene content, suggesting that the dnaQ-yafV
region represents a hotspot for insertions into the backbone
sequence.
Analyses of the nucleotide sequence from the correct PAI
IICFT073 revealed the presence of 116 ORFs (c0253 to c0368).
Homology searches indicated a close relationship between this
PicU-encoding PAI and a 71.6-kb PAI previously character-
ized in E. coli CFT073 and designated PAI IICFT073 (43).
Although both islands share the same first 48 ORFs (repre-
senting only 30% of the 100-kb island described here), the
remainder of the island is significantly different. Further anal-
ysis of the 71.6-kb island revealed it to be a mosaic, comprised
of two distinct regions of the E. coli CFT073 genome separated
by an inverted repeat of 1,515 bp (Fig. 1B), suggesting the
sequence of this putative 71.6-kb island was incorrectly assem-
bled in the first instance. We have retained the PAI IICFT073
nomenclature for the corrected island.
Twenty-four ORFs from the correct PAI IICFT073 were as-
sociated with IS, phage and mobility genes, and 67 encoded
hypothetical proteins of unknown function. The remainder of
the genes, including picU, were associated with virulence and
are listed in Table 2. As mentioned above, Pic was character-
ized previously in EAEC 042 and S. flexneri 2a (21). PAI
IICFT073 is distinct in size, organization, and gene composition
from the pic-containing islands of the S. flexneri 2a and E. coli
042 (Fig. 1C). Furthermore, the islands are inserted in different
regions in each strain, suggesting that pic and picU are mobile
elements and can move independently of the PAI.
Including picU, PAI IICFT073 contains three loci that are
associated with protein secretion. The adjacent locus (c0360 to
c0363) encodes a type I protein secretion system, designated
the tos locus (for “type one secretion”). In silico analyses dem-
onstrate that TosC encodes a TolC-like outer membrane pro-
tein, TosB encodes an ABC-transporter protein of the HlyB
family, TosD encodes a protein of the HlyD family of mem-
TABLE 1. PCR primers used in this study
Target
(orientation)a Primer sequence (5–3) Genomic position
b
PAI (F) AGCGGTAGTTCAGTCGGTTAGAATA 248556–248580
PAI (R) TTTTATGATAAGCGTCATCTGTTCC 349062–349086
fbp (F) TTGCTCGTCGGGCTGAAAAAGTTGT 278466–278490
fbp (R) TTGCACCATCCACTATCACCATCGA 279008–278984
efu (F) TATCGTGTTTATTCCCGCTATGG 302752–302774
efu (R) CCCCTCGGAGAAAACCAGATATT 303203–303181
etp (F) CCACCATCACGGCAGGACAACTCAC 315712–315736
etp (R) CCCGGTTTTCCAGTCGTTCAGCCTC 317178–317154
picU (F) TCAGGCCGGTAAGAACAGCAAAAT 327844–327821
picU (R) ACGGTAAGAGTGTGGATGGCGGAGTC 327473–327498
tos (F) ATAGCATCACTGGCCACCCGTTTCC 338629–338605
tos (F) CAGTTTTTGAGGTTACGGTTGACGG 343750–343774
chuA (F) GACGAACCAACGGTCAGGAT
chuA (R) TGCCGCCAGTACCAAAGACA
ypaA (F) TGAAGTGTCAGGAGACGCTG
ypaA (R) ATGGAGAATGCGTTCCTCAAC
tspE4C2 GAGTAATGTCGGGGCATTCA
tspE4C2 CGCGCCAACAAAGTATTACG
a F, forward; R, reverse.
b Relative to the UPEC strain CFT073 genome (53).
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FIG. 1. Genetic organization of the PAI IICFT073. (A) Comparison of the E. coli CFT073 PAI IICFT073 and flanking sequences with the
equivalent region of E. coli K-12 MG1655. ORFs common to E. coli K-12 and E. coli CFT073 are white. Other ORFs are indicated as follows:
ORFs with no homology to anything in the GenBank databases are gray; ORFs with homology to genes associated with IS elements, phage, and
mobility genes are yellow; ORFs with homology to genes of unknown function are blue; and ORFs associated with putative virulence determinants
are red. Regions that may be associated with virulence are designated by thick black lines above the PAI and represent the fbp iron-sequestering
locus (a), the efu sugar-metabolizing loci (b), the etp two-partner secretion system (c), the picU autotransporter (d), and the tos type I secretion
system (e). (B) Comparison of the E. coli CFT073 PAI IICFT073 from the complete genome (54) with that of the previously published by Rasko
et al. (43). The earlier sequence appears to be comprised of three distinct regions of the E. coli CFT073 genome. The numbers on the bottom
represent the position of the different DNA fragments within the E. coli CFT073 genome. (C) Comparison of PAI IICFT073 from E. coli CFT073
with the pic-containing islands of S. flexneri and E. coli 042. The islands are divergent in size, gene complement, organization and chromosomal
location. Figures represent the point of insertion into the chromosome of each strain.
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brane fusion proteins, and TosA encodes a 164-kDa repetitive
protein similar to hemagglutinins and hemolysins. In BLAST
searches against finished and unfinished microbial genomes,
TosC, TosB, and TosD were found to be most similar to hy-
pothetical proteins encoded by a cluster of three ORFs in the
unfinished Dichelobacter nodosus VCS1703A genome (28, 56,
and 53% identity, respectively), whereas the best TosA homo-
logue was found in Ralstonia solanacearum (24% identity) (47).
Among homologues of known function, TosC is most similar to
those required for protein secretion (as opposed to cation or
drug efflux), suggesting that TosA may be the cognate sub-
strate for this putative export system. With analogy to the
haemolysin TolC-HlyBD system (17, 28, 52, 53), TosC would
form a trimeric 12-stranded -barrel pore in the outer mem-
brane connected to an elongated -helical trans-periplasmic
channel, which would transiently dock with the TosD/TosB
translocase complex at the inner membrane to facilitate the
secretion of TosA from the cytoplasm. A multiple alignment of
TosC with other TolC homologues indicates that a notable
sequence gap in TosC falls within the extracellular loop linking
-strands 4 and 5 in the  barrel. Although this would produce
a loop several residues shorter than the equivalent loop in
other TolC homologues (28, 29), it appears from the three-
dimensional model of TosC that -strands 4 and 5 are of
sufficient length to span the hydrophobic core of the outer
membrane lipid bilayer (Fig. 2).
The third protein secretion locus resembles a TPSS (desig-
nated etp for “E. coli two-partner secretion”), which normally
consists of two genes encoding a secreted effector molecule
and a transmembrane pore-forming domain (25). The etpA
gene (c0345) encodes a putative effector molecule of 328.4-
kDa representing the largest protein encoded by E. coli
CFT073 and which shows homology with the HecA coloniza-
tion factor of Erwinia chrysanthemi (30% identity over 1,712
amino acids) and other large proteins secreted via the TPSS
(45). The initial annotation indicated that EtpB, the pore-
forming domain, was nonfunctional being represented by three
pseudogenes (c0342 to c0344). However, closer inspection re-
vealed c0342 and c0343 constitute one ORF. Furthermore,
scrutiny of c0343 and c0344 suggested that they might repre-
sent a single ORF and that a small sequencing error intro-
duced an in-frame stop codon (Amber) into the sequence in
place of a tryptophan residue (TGG3TAG). However, we
resequenced this region and confirmed the presence of an
in-frame Amber stop codon. An Amber stop codon is relatively
infrequent in E. coli (30); this, combined with the fact that this
is an in-frame termination signal, suggests that this termination
signal may be suppressed, with one of a number of potential
amino acids being inserted at this position. Furthermore, etpB
of UPEC strain 536 is an intact ORF, suggesting that this is a
functional locus (13) and not a pseudogene; however, empiri-
cal evidence is needed to clarify this.
A further locus (c0294 to c0297) designated fbp (for “ferric
binding protein”) may be involved in the acquisition of iron. In
silico analyses revealed that FbpA belongs to the TonB-depen-
dent family of outer membrane receptor proteins mostly asso-
ciated with iron transport, whereas FbpB, FbpD, and FbpC
belong to the ferric enterobactin family of iron sequestering
proteins, possessing homology to the FepB, FepD, and FepC
proteins, respectively.
The remaining virulence-associated locus comprises genes
associated with sugar metabolism (c0318 to c0336). These loci
appear to be involved with the ability to degrade the specific
carbohydrates fucose and pectin, and we have designated this
the efu locus (for “E. coli fucose metabolism”).
Distribution of PAI IICFT073 genes among the ECOR collec-
tion. To determine the phylogenetic distribution of PAI
IICFT073, we surveyed the well-defined ECOR collection, which
is richly varied in terms of phylogeny and zoological and geo-
graphical strain origins (38). Using primers corresponding to
dnaQ and yafV, which flank either side of the aspV tRNA site,
the presence of an appropriately sized PCR product could be
detected in amplifications with E. coli K-12 genomic DNA. In
contrast, and as expected, no product could be detected in
reactions with E. coli CFT073 DNA. The failure of the PCR
indicated the presence of PAI IICFT073. Similar reactions with
genomic DNA preparations from all members of the ECOR
collection yielded negative reactions comparable to those of
control E. coli CFT073, indicating that every strain within the
ECOR collection possessed an insert in this region and sug-
gesting that the aspV tRNA site is a hotspot for recombination.
The prevalence of the five PAI IICFT073-encoded virulence-
associated loci among the ECOR collection is shown in Fig. 3.
The fbp locus was found to have low prevalence among non-B2
ECOR strains (3.5%) and a significantly higher prevalence
among the B2 group (66.7%; P  0.00000003). The genes for
the carbohydrate metabolism locus (efu) were found at a sig-
nificantly higher frequency in the B2 phylogenetic locus (80%)
than the non-B2 group (29.8%; P  0.0006), even though this
locus demonstrated the widest distribution among the non-B2
FIG. 2. (A) Homology model of the TosC trimer. The individual
protomers are colored blue, yellow, and green. A side view of the TosC
trimer embedded in the bacterial outer membrane is shown. (B) Top
view of the TosC trimer in the same orientation as in panel A dem-
onstrating the periplasmic channel formed by the TosC trimer. The
TosC homology model was generated by using the Swissmodel server
(www.expasy.org/swissmod/) in alignment mode with the TolC crystal
structure (1EK9) as a template. The TosC-TolC pairwise alignment on
which the model is based was manually edited to ensure the integrity
of conserved secondary structures and residues according to the mul-
tiple alignment of 115 TolC homologues from the COG1538 group.
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TABLE 2. PAI IICFT073 virulence-associated loci
Locus GenPept IDa Position Product Homology
Fbp locus
c0294 AAN78782.1 274013276178 FbpA TonB-dependent receptor Putative TonB-dependent receptor Erwinia
carotovora (CAG76463)
c0295 AAN78783.1 276186277178 FbpB periplasmic siderophore-binding
protein
Putative iron-chelating periplasmic binding
protein Erwinia carotovora (CAG76462)
c0296 AAN78784.1 277197278255 FbpD ABC-type Fe3 siderophore transport
permease
Putative ABC transport protein Salmonella
enterica serovar Typhimurium LT2
(AAL19708)
c0297 AAN78785.1 278252279019 FbpC ABC-type Fe3 siderophores transport
ATPase components
Putative Fe3 siderophore transport ATPase
component Salmonella enterica serovar
Typhimurium LT2 (AAL19709)
Efu locus
c0318 AAN78806.1 Complement
(289106289744)
EfuA sugar-phosphate isomerase Putative sugar-phosphate isomerase
Xanthomonas axonopodis (AAM35062)
c0319 AAN78807.1 289986291158 EfuB oligogalacturonide lyase Putative oligogalacturonate lyase Erwinia
carotovora (CAG75329)
c0321 AAN78809.1 291188291988 EfuC gluconate 5-dehydrogenase Putative 5-keto-D-gluconate 5-reductase
Streptococcus pyogenes (AAM79055)
c0322 AAN78810.1 292732294246 EfuD oligogalacturonide transporter Putative oligogalacturonide transporter
Erwinia carotovora (CAG73730)
c0323 AAN78811.1 294176296482 EfuE exopolygalacturonate lyase Putative exopolygalacturonate lyase Erwinia
carotovora (CAG77405)
c0330 AAN78818.1 Complement
(300643301428)
EfuF deoxyribose operon repressor Hypothetical protein Escherichia coli 536
(CAE85174)
c0331 AAN78819.1 301731302651 EfuG ribokinase Hypothetical protein Escherichia coli 536
(CAE85173)
c0332 AAN78820.1 302679303995 EfuH L-fucose permease Hypothetical protein Escherichia coli 536
(CAE85172)
c0333 AAN78821.1 304007305020 EfuI cytoplasmic protein Hypothetical protein Escherichia coli 536
(CAE85171)
c0334 AAN78822.1 Complement
(305943307199)
EfuJ sugar-specific permease Unknown protein Escherichia coli AL862
(AAK27335)
c0335 AAN78823.1 Complement
(307212307499)
EfuK sugar phosphotransferase component
II B
Unknown protein Escherichia coli AL862
(AAK27336)
c0336 AAN78824.1 Complement
(307515307958)
EfuL PTS system, mannitol (cryptic)-specific
IIA component
Unknown protein Escherichia coli AL862
(AAK27337)
Eth locus
c0342 310860312131 EthB two-partner secretion system
membrane exporter
Hypothetical protein Escherichia coli 536
(CAD42056)
c0343 312310312684 EthB two-partner secretion system
membrane exporter
Hypothetical protein Escherichia coli 536
(CAD42056)
c0344 312321312632 EthB two-partner secretion system
membrane exporter
Hypothetical protein Escherichia coli 536
(CAD42056)
c0345 AAN78830.1 312645322295 EthA two-partner secretion system
exoprotein
Hypothetical protein Escherichia coli 536
(CAD42055)
PicU locus
c0350 AAN78833.1 Complement
(326209330324)
PicU serine protease precursor Pic serine protease precursor Shigella flexneri
2a (AAD23953)
Tos locus
c0360 AAN78841.1 336046337293 TosC TolC-like outer membrane protein Putative outer membrane protein Ralstonia
eutropha (ZP_00170441)
c0361 AAN78842.1 337318339465 TosB HlyB-like cytoplasmic membrane
export protein
Putative ABC-type exporter Ralstonia
eutropha (ZP_00170444)
c0362 AAN78843.1 339511340773 TosD HlyD-like membrane spanning export
protein
Putative HlyD family secretion protein
Salmonella enterica serovar Typhimurium
LT2 (AAL21580)
c0363 AAN78844.1 340972345804 TosA RTX family exoprotein A gene Unknown protein Synechocystis sp. strain
PCC 6803 (NP_442018)
a ID, identification code.
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FIG. 3. Distribution of PAI IICFT073 virulence associated loci among the ECOR collection. A phylogenetic tree of the ECOR isolates shows
the distribution of the five virulence-associated loci, where each loci is represented by a shaded box as indicated in the figure. The number of the
ECOR isolate is given in boldface, and each of the major phylogenetic branches are indicated. The complete complement of virulence associated
loci is preferentially associated with the B2 phylogentic cluster. Adapted from reference 23 with permission.
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isolates. The two-partner secretion system locus (etp) was also
found more frequently in the B2 ECOR group (53.3%) than in
non-B2 strains (7.0%; P 0.0002). The picU gene was found in
7.0% (4 of 57) non-B2 ECOR strains, which was significantly
less than among the B2 group (53.3%; P  0.0008). The pres-
ence of the tos locus also occurred at a higher frequency in the
B2 cluster (60%) than in the non B2 groups (8.8%; P 
0.00007). Interestingly, the etp and tos loci are found only in
strains in which the efu locus was detected. None of the re-
maining loci demonstrated a strict concomitant presence.
Only two non-B2 strains were positive for the full comple-
ment of the PAI IICFT073 virulence associated loci, namely,
ECOR23, an ECOR group A strain from a healthy elephant
and ECOR58, an ECOR group B1 strain from a healthy lion
(38). To ensure that these positive results did not arise through
contamination of the original stocks with a B2 isolate, the
phylogenetic grouping was determined for each strain by using
the method described by Clermont et al. (7). These experi-
ments confirmed that ECOR23 belonged to group A and
ECOR58 to the B1 group, indicating that PAI IICFT073 had
been acquired by horizontal transfer.
Prevalence of PAI IICFT073 genes among UTI isolates. To
determine whether PAI IICFT073 was associated with a partic-
ular UTI, the presence of the five virulence-associated loci
were detected by PCR in a collection of pathogenic E. coli
strains isolated from patients with cystitis, pyelonephritis, and
prostatitis. The results are shown in Fig. 4.
When the cystitis and pyelonephritis strains were analyzed,
no statistically significant difference was observed between the
distribution of the fbp locus (57.9% versus 59.3%), the efu
locus (55.3% versus 48.1%), the etp locus (52.6% versus
48.1%) the picU locus (34.2% versus 40.7%), or the tos locus
(34.2% versus 22.2%). Similarly, no statistically significant dif-
ference was observed between the distribution of the etp and
picU loci when prostatitis isolates were compared to cystitis
strains (72.4% versus 52.6% and 44.8% versus 34.2%, respec-
tively) or pyelonephritis strains (72.4% versus 48.1% and
44.8% versus 40.7%, respectively). In contrast, the iron-bind-
ing locus fbp demonstrates a higher prevalence in prostatitis
strains compared to cystitis (82.8% versus 57.9%, P  0.03)
and pyelonephritis (82.8% versus 59.3%, P  0.05). In a com-
parable fashion, the distribution of efu, the sugar metabolizing
locus, in prostatitis isolates, is significantly higher compared to
cystitis (89.7% versus 55.3%, P  0.003) and pyelonephritis
(89.7% versus 48.1%, P  0.001). Finally, a negative correla-
tion was observed between the distribution of the tos locus in
prostatitis strains and pyelonephritis isolates (22.2% versus
48.3%, P  0.05) but not between prostatitis and cystitis iso-
lates (48.3% versus 34.2%).
In all cases the presence of the tos locus was found concur-
rently with the fbp and efu loci and, with the exception of one
strain, with the picU gene. The distributions of the hly, fim, aer,
cnf1, pap, sat, and prs loci have previously been described for
this collection of UTI isolates (46). Comparison of the current
data with the previous data did not reveal a strict concomitant
correlation between the presence of any of the previously in-
vestigated loci and the data generated for the present study.
Prevalence of PAI IICFT073 genes among E. coli septicemia
isolates. The prototypical uropathogenic E. coli isolate
CFT073 was isolated from the blood of a woman suffering from
pyelonephritis, indicating that it had the capacity to invade the
bloodstream (35). To investigate whether PAI IICFT073 con-
tributed to the ability of E. coli to invade the bloodstream, the
distribution of the five virulence-associated loci in 43 strains of
E. coli isolated from patients with septicemia was examined by
PCR (Fig. 4). There were no statistically significant differences
between the prevalences of any of the PAI IICFT073 loci in the
septicemia and pyelonephritis isolates. Similarly, there was no
statistically significant difference between the distribution of
the fbp, efu, and picU loci in the septicemia isolates compared
to the cystitis isolates, and no difference was observed in the
distribution of the picU gene when septicemia isolates were
compared to the prostatitis strains. Interestingly, the tos and
etp loci demonstrated a statistically lower prevalence in the
septicemia isolates than in cystitis isolates (P  0.02 and P 
0.05, respectively).
Unexpectedly, the prevalence of the efu, tos, etp, and fbp loci
was significantly lower in the septicemia isolates than in the
prostatitis isolates (P  0.05, P  0.0009, P  0.0007, and P 
0.002, respectively). To determine whether the distribution was
altered by a population of septicemia isolates that was not
representative of the B2 phylogenetic cluster, the phylogenetic
grouping was determined for each isolate by using the method
described by Clermont et al. This analysis revealed that the
collection of septicemia isolates was composed of 26 strains
from the B2 phylogenetic group, 4 strains from the B1 group,
7 strains from the D group, and 3 strains from the A group.
Comparison of the B2 septicemia isolates with the ECOR B2
isolates revealed no statistically significant difference in the
prevalence of efu, picU, etp, or fbp. Interestingly, the tos locus
was significantly underrepresented in the blood-borne isolates
when the two B2 groups were compared (60% versus 19.2%, P
 0.02). Comparison of the distribution of the PAI IICFT073
loci among the nonB2 ECOR collection and the nonB2 septi-
cemia isolates revealed no statistical difference between the
FIG. 4. Prevalence of PAI IICFT073 virulence associated loci in E.
coli clinical isolates. The fbp, efu, etp, picU, and tos loci were detected
by PCR in clinical isolates of E. coli. Prevalence is indicated as a
percentage of the total population of strains associated with each
clinical syndrome. ❋, A statistically significant difference between
prostatitis and cystitis;, #, a statistically significant difference between
prostatitis and pyelonephritis; , a statistically significant difference
between prostatitis and septicemia isolates; {, a statistically significant
difference between cystitis and septicemia isolates.
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prevalence of the efu, tos, etp, or fbp loci. Surprisingly, the
nonB2 septicemia isolates demonstrated a higher prevalence
of picU than the nonB2 ECOR collection (58.9% versus
10.5%, P  0.0001) and the B2 septicemia isolates (58.9%
versus 23.1%, P  0.0008).
DISCUSSION
The number of proteins identified in gram-negative bacteria
that are secreted via the autotransporter secretion pathway
(11, 12) has grown almost exponentially since the initial de-
scription of the secretion of gonococcal immunoglobulin A1
protease (42). Recently, we described the existence of several
autotransporters in UPEC strain CFT073, including the
SPATE protein PicU (40). Further investigation revealed PicU
was encoded on a 100-kb PAI inserted at the aspV tRNA locus.
Like other PAIs, PAI IICFT073 possesses several loci, in addi-
tion to the picU locus, which may be involved in virulence.
Among these are a member of the two-partner secretion sys-
tem (etp), a type I secretion system (tos), iron acquisition genes
(fbp), and a carbohydrate metabolism locus (efu). Interestingly,
the genetic content of the PAI encoding PicU is homologous
(30% identical) to a PAI (PAI IICFT073) that was reported as
being inserted in the chromosomal backbone of E. coli in a
similar position (43). The reason for the discrepancy between
the complete genome sequence and that published by Rasko et
al. (43) is unclear but could be due to several reasons, including
a recombination event, concatamerization of inserts in the
cosmid clones used to assemble the sequence of Rasko et al.
(43), or misassembly of the sequenced regions. Nevertheless,
we have retained the PAI IICFT073 nomenclature for the PicU-
encoding island.
E. coli is a highly clonal species represented by four major
phylogentic groups (A, B1, B2, and D) (26). Most extra-intes-
tinal pathogenic E. coli strains, including those with the most
robust virulence factor repertoires and those that are most able
to infect noncompromised hosts, derive from phylogenetic
group B2 with group D representing the second largest group
contributing to the extraintestinal clones (26, 27, 55). In con-
trast, diarrheagenic pathotypes occur almost exclusively in the
A, B1, D, and ungrouped phylogenetic groups (26). The full
complement of virulence associated loci was found in eight of
the 15 B2 isolates, however six of these were clustered to-
gether, suggesting that acquisition of PAI IICFT073 occurred
late in the divergence of the B2 cluster and that other strains
have acquired the island by horizontal gene transfer, a hypoth-
esis supported by the observation of the intact PAI in ECOR23
and ECOR58, group A and B1 strains, respectively. However,
an alternative hypothesis is that PAI IICFT073 was acquired
early in the B2 cluster and that various genes were lost by
mutational attrition. This hypothesis is supported by the pres-
ence of the full complement of genes on two additional
branches of the B2 cluster. Nevertheless, it is clear that the
island and its constituent loci are mainly associated with the B2
cluster, which is representative of extraintestinal infectious or-
ganisms, and commensal rectal isolates.
A question that remains unanswered is whether the more
invasive extraintestinal strains, such as those which cause py-
elonephritis, prostatitis, or septicemia, are simply more viru-
lent than their counterpart cystitis isolates or whether they are
separate pathogens with specialized repertoires of virulence
factors that have evolved to allow colonization of their specific
niches. Previous investigations by many different groups work-
ing with many different pathogens have demonstrated that the
acquisition of iron is often essential for full virulence (8, 16,
44). In addition, many PAIs possess iron acquisition mecha-
nisms (4, 5, 31). The locus encoding the FbpA-D iron sid-
erophore system was previously shown to be associated with
UPEC and to be more represented in these pathogens than in
intestinal isolates of E. coli (43). However, in the same study
Rasko et al. suggested that the presence of this locus was more
strongly correlated with survival in the bladder because of the
presence of the locus in a significantly greater number of cys-
titis isolates (43). In contrast, we found no difference between
the presence of the fbp locus in pyelonephritis and cystitis
strains. However, prostatitis isolates showed a significantly
greater prevalence of the fbp locus than cystitis or pyelonephri-
tis isolates, indicating the greater virulence of these strains.
The existence of this locus and additional iron acquisition loci
suggests that E. coli CFT073 may be adept at scavenging this
important nutrient.
The presence of the sugar-metabolizing locus (efu) within
the PAI has no obvious connection with a role in pathogenesis
of E. coli CFT073. However, recent signature-tagged mutagen-
esis analyses of Klebsiella pneumoniae identified mutants in
three separate genes in the fucose-metabolizing locus that
were unable to colonize the intestine of mice (32). Further-
more, in Bacteroides thetaiotaomicron, a commensal intestinal
isolate, expression of the fucose metabolic pathway is coordi-
nated with the production of fucosylated glycans in enterocytes
that are hypothesized to act a receptors for this organism (24).
Interestingly, the presence in certain women of fucosylated
structures on the surface of uroepithelial cells appears to have
a protective effect from UTI (48). The extraordinary virulence
of E. coli CFT073 may be due in part to the ability to degrade
these fucosylated structures. Although a role for the efu locus
specifically in the pathogenesis of UTI appears unlikely due to
its wide distribution among all phylogenetic groups of E. coli,
and an equal distribution among cystitis, pyelonephritis, and
septicemia strains, it is interesting that three of the loci (c0334
to c0336) are among the top 15 genes upregulated during
growth of bacteria in urine (50).
A range of different adhesive factors have been described for
extraintestinal pathogenic E. coli, including the type 1, P, and
S fimbrial systems (37). Several groups have demonstrated that
possession of these different adhesive systems contributes to
the ability of UPEC to infect different niches, e.g., expression
of P fimbriae contributes to an ascending UTI leading to py-
elonephritis (19). Unlike the fimbrial systems, the etpBA locus
encodes a putative adhesin secreted via a two-partner secretion
system in which EtpA represents the secreted protein and
EtpB the transmembrane pore that facilitates secretion of
EtpA (25). EtpA demonstrates a high level of similarity to
HecA of Erwinia chrysanthemi and filamentous hemagglutinin
of Bordetella pertussis; both proteins have been shown to be
important in the pathogenesis of disease by mediating adher-
ence and bacterial cell aggregation (45, 51), suggesting that
EtpA might lead to colonization of specific niche within the
urinary tract. Indeed, the presence of the etp locus was ob-
served at a statistically higher frequency among prostatitis
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strains compared to cystitis and pyelonephritis. Interestingly,
filamentous hemagglutinin is a component of the acellular
pertussis vaccines currently in use (41), suggesting that this
homologous protein might offer potential for therapeutic uses.
Members of the SPATE family of autotransporters are pro-
teins from E. coli and Shigella spp. that have been widely
implicated in virulence (22). Previous investigations in our lab
demonstrated that the SPATE protein PicU is a multifunc-
tional enzyme which, like its enteric counterpart (Pic), can
digest mucin (21, 40). Since the urinary tract is lined with
mucin, PicU may play a role in breaching this protective layer
to allow onset of disease. Indeed, previous data have shown
that disruption of the urinary tract mucus layer prior to bac-
terial challenge increases the level of colonization and the
severity of disease (9). Previously, we found picU to be present
in 22.5% of UTI isolates compared to only 12% of rectal
isolates with no statistical difference between cystitis and py-
elonephritis (40), whereas in the current study we found no
difference between cystitis, pyelonephritis, prostatitis, or sep-
ticemia isolates. In contrast, Heimer et al. (20) detected picU in
a significantly higher number of pyelonephritis strains than
cystitis isolates; however, the reasons for the disparate results
is not clear. Perhaps the most interesting observation regarding
picU is its distribution among the septicemia isolates. Although
the prevalence of picU among the B2 phylogenetic groups in
the ECOR and septicemia isolates is similar, among non-B2
groups it demonstrated a higher prevalence in the septicemia
isolates, a finding which could be explained if picU contributed
to the ability of bacteria to invade the bloodstream or to sur-
vive within the bloodstream. In this respect Hbp, a homologue
of PicU, has been demonstrated to recruit iron through the
degradation of hemoglobin, suggesting that PicU might have
the same ability (39). The ability of PicU or Pic to scavenge
iron in a similar fashion has yet to be investigated.
Pfam and SMART domain searches clearly show that TosB,
TosD, and TosC are members of the HlyB, HlyD, and TolC
protein families, respectively. Although TosC shares much
lower identity with its respective homologues than TosB and
TosD, this is a typical feature of all TolC-like proteins (28).
Importantly, TosC shares the stabilizing ring of aromatic res-
idues at the base of the -barrel and the majority of conserved
proline residues in the interdomain region between the -bar-
rel and the periplasmic helices (Fig. 2). In general, the closest
homologues of TosB and TosD are encoded in clusters in
association with genes encoding TosA and TosC homologues,
although the order is not always conserved with E. coli
CFT073. Given the close association of tosA with tosCDB, it
appears likely, but not certain, that the 164-kDa product of this
gene is secreted in a type I-dependent fashion via the TosBDC
secretion apparatus. TosA is a highly repetitive protein, with
several glycine- and leucine-rich repeats that appear to be
similar to the calcium-binding repeats found in the RTX family
of type I-secreted proteins. Classical RTX toxins, such as
HlyA, share low-level identity over the first 500 to 600 residues,
followed by a discrete region of calcium-binding nonamers and
a C-terminal secretion domain (28). In contrast, TosA and its
close homologues have no significant similarity to the N-ter-
minal domain of RTX toxins and are not found in operons
encoding HlyC homologs (the acyl modification enzyme re-
quired for activation of RTX toxins); therefore, they represent
a distinct family of large repetitive proteins. The presence of a
single transmembrane domain in the N-terminal region of
TosA suggests that, postsecretion, the molecule may be teth-
ered to the outer membrane and act as an adhesin. Interest-
ingly, although orthologous clusters are found throughout the
Enterobacteriaceae, including the majority of Salmonella spe-
cies, no function has yet been ascribed to a TosA homologue.
However, the tos locus is present at a low frequency in pyelo-
nephritis and septicemia isolates compared to cystitis, suggest-
ing that expression of this adhesin may inhibit the ability of
bacteria to invade renal tissue and the bloodstream but may
contribute to bladder colonization.
In summary, we have demonstrated that the presence of PAI
IICFT073 is associated with extraintestinal group B2 isolates of
E. coli. Furthermore, PAI IICFT073 is more prevalent in strains
causing prostatitis than cystitis or pyelonephritis, and the pres-
ence of the fbp, efu, etp, and picU loci does not contribute to
ascending urinary tract infections, whereas the presence of the
TosA adhesin may inhibit the ability of E. coli strains to ascend
the urinary tract and/or invade the bloodstream. Although fbp,
efu, etp, and tos do not contribute to the ability of E. coli to
invade the bloodstream, the presence of picU may enhance the
ability of E. coli from groups A, B1, D, and E to survive or
invade the bloodstream. The full contribution of these loci to
prostatitis is currently under investigation.
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